Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 13/20 | 0.33 |
| ▸ | HTR2B | P41595 | 11/20 | 0.33 |
| ▸ | HTR2A | P28223 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3435214 | 0.76 | — | — | |
| SCHEMBL1138718 | 0.76 | HTR6 (0.46) | HTR6 | |
| SCHEMBL3059717 | 0.71 | — | — | |
| SCHEMBL5408429 | 0.70 | HTR6 (0.44) | HTR6HTR2CHTR2BHTR2A | |
| SCHEMBL2553676 | 0.69 | HTR6 (0.38) | HTR6HTR2CHTR2B | |
| SCHEMBL17703988 | 0.69 | MEN1 (0.30) | — | |
| SCHEMBL17675373 | 0.69 | — | — | |
| SCHEMBL23478571 | 0.68 | — | — | |
| SCHEMBL16529635 | 0.68 | — | — | |
| SCHEMBL6216657 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1253140-B1 | PROCESS FOR CYCLIZING OPTICALLY ACTIVE 4-AMINO-2-HALOGENOBUTYRIC ACIDS | KANEKA CORP (JP) | 2005-01-12 | — | — | EP | claimed |
| US-6747161-B2 | AZETIDINE-2-CARBOXYLIC ACID; ALKALINE EARTH METAL OXIDE OR HYDROXIDE, OR AMINE; HIGH OPTICAL YIELD | KANEKA CORPORATION (JP) | 2004-06-08 | — | — | US | claimed |
| US-20030109719-A1 | Process for cyclizing optically active 4-amino-2-halogenobutyric acids | SAKA YASUHIRO (JP) | 2003-06-12 | — | — | US | claimed |
| EP-1253140-A1 | PROCESS FOR CYCLIZING OPTICALLY ACTIVE 4-AMINO-2-HALOGENOBUTYRIC ACIDS | KANEKA CORPORATION (JP) | 2002-10-30 | — | — | EP | claimed |
| US-5145889-A | For light-emitting diodes | KABUSHIKI KAISHA TOSHIBA (JP) | 1992-09-08 | — | — | US | claimed |
| US-12187843-B2 | Liquid compression molding or encapsulant compositions | HENKEL AG & CO. KGAA (DE) | 2025-01-07 | — | — | US | disclosed |
| US-20240301129-A1 | LIQUID MOLD COMPOUNDS, REACTION PRODUCTS OF WHICH BECOME PLATABLE UPON EXPOSURE TO LASER ENERGY | HENKEL AG & CO KGAA (DE) | 2024-09-12 | — | — | US | disclosed |
| CN-118266072-A | Liquid molding compounds, and reaction products thereof that become electroplatable when exposed to laser energy | 汉高股份有限及两合公司 | 2024-06-28 | — | — | CN | disclosed |
| EP-1253140-B1 | PROCESS FOR CYCLIZING OPTICALLY ACTIVE 4-AMINO-2-HALOGENOBUTYRIC ACIDS | KANEKA CORP (JP) | 2005-01-12 | — | — | EP | disclosed |
| US-6747161-B2 | AZETIDINE-2-CARBOXYLIC ACID; ALKALINE EARTH METAL OXIDE OR HYDROXIDE, OR AMINE; HIGH OPTICAL YIELD | KANEKA CORPORATION (JP) | 2004-06-08 | — | — | US | disclosed |
| US-20030109719-A1 | Process for cyclizing optically active 4-amino-2-halogenobutyric acids | SAKA YASUHIRO (JP) | 2003-06-12 | — | — | US | disclosed |
| EP-1253140-A1 | PROCESS FOR CYCLIZING OPTICALLY ACTIVE 4-AMINO-2-HALOGENOBUTYRIC ACIDS | KANEKA CORPORATION (JP) | 2002-10-30 | — | — | EP | disclosed |
| US-5145889-A | For light-emitting diodes | KABUSHIKI KAISHA TOSHIBA (JP) | 1992-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030109719-A1 | Process for cyclizing optically active 4-amino-2-halogenobutyric acids | AOC2, AZI2, ALAD | HTR6 2501/4885HTR2C 1503/4885HTR2B 401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.